Development of a Population Pharmacokinetic Gabapentin Model Leveraging Therapeutic Drug Monitoring Concentrations

<b>Background/Objectives:</b> Gabapentin has variable pharmacokinetics (PK), which contributes to difficulty in dosing and increased risk of adverse events. The objective of this study was to leverage gabapentin concentrations from therapeutic drug monitoring (TDM) to develop a populatio...

Full description

Saved in:
Bibliographic Details
Main Authors: Firas Al-Zubaydi, Andrew Wassef, Leonid Kagan, Luigi Brunetti
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/16/12/1514
Tags: Add Tag
No Tags, Be the first to tag this record!